<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03933033</url>
  </required_header>
  <id_info>
    <org_study_id>Erbium Yag</org_study_id>
    <nct_id>NCT03933033</nct_id>
  </id_info>
  <brief_title>Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars</brief_title>
  <official_title>Fractional Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars: A Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aswan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>South Valley University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aswan University Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aim to assess the efficacy of Er-YAG laser 2940nm and PRP as a single line of
      treatment in comparison with combined treatment in atrophic post acne scars.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2017</start_date>
  <completion_date type="Actual">February 28, 2019</completion_date>
  <primary_completion_date type="Actual">August 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in grade of acne scares according toQualitative scarring grading system of Goodman and Baron</measure>
    <time_frame>6 months</time_frame>
    <description>Grade of acne scares improvement after treatment</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in clinical appearance of acne scare accordinga four-point scale for assessment of clinical improvement of skin smoothness</measure>
    <time_frame>6 month</time_frame>
    <description>improvement of acne scares as evaluated by sequential photos</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in patient satisfaction usinga four-point scale; Grade 4 highly satisfied, Grade 3 satisfied, Grade 2 neutral and Grade 1 dissatisfied</measure>
    <time_frame>6 month</time_frame>
    <description>increase in patient satisfaction after treatment</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">75</enrollment>
  <condition>Acne Vulgaris</condition>
  <condition>Scars</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treated with platelet rich plasma</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treated with Erbium Yag Laser</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>treated with both line of treatments</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Fractional Erbium Yağ Laser</intervention_name>
    <description>Multiple sessions of Fractional Erbium Yağ Laser</description>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Platelet Rich Plasma</intervention_name>
    <description>Multiple injections of Platelet Rich Plasma</description>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_label>Group C</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with atrophic post acne scars classified on the basis of Goodman and Baron's
             Qualitative classification, no active acne lesions and patients with atrophic scars
             only

        Exclusion Criteria:

          -  patients with positive history of keloidal tendency, positive history of bleeding
             tendency, platelet disorder, patients with any acute infection on face like, herpes,
             folliculitis, patients with HIV, HBsAg, patients with a history of autoimmune diseases
             or patients on immunosuppressive drugs.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>38 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Aswan University Hospital</name>
      <address>
        <city>Aswan</city>
        <zip>81528</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>April 25, 2019</study_first_submitted>
  <study_first_submitted_qc>April 27, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 1, 2019</study_first_posted>
  <last_update_submitted>April 27, 2019</last_update_submitted>
  <last_update_submitted_qc>April 27, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">May 1, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Aswan University Hospital</investigator_affiliation>
    <investigator_full_name>Moustafa A. El Taieb</investigator_full_name>
    <investigator_title>Ass. Prof. of Dermatology, Venereology and Andrology</investigator_title>
  </responsible_party>
  <keyword>Acne scars</keyword>
  <keyword>Erbium-YAG laser</keyword>
  <keyword>platelet-rich plasma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

